The contribution of Asian scientists to global research in andrology

Asian Journal of Andrology

Volumn 1, Issue 1-2, 1999, Pages 7-12

  Waites, Geoffrey M H ^a,b,c,d,e  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF SYDNEY   (Australia)

^c International Society of Andrology   (Finland)

^d WHO   (Australia)

^e NONE   (Australia)

Author keywords

Andrology; Asia; Contraception; Gossypol; Hormonal methods; Tripterygium; Vas occlusion; World Health Organization

Indexed keywords

ANTISPERMATOGENIC AGENT; GOSSYPOL; HERBACEOUS AGENT;

ASIA; CONTRACEPTION; HUMAN; MALE; RESEARCH; REVIEW; TRIPTERYGIUM; UROLOGY;

ANTISPERMATOGENIC AGENTS; ASIA; CONTRACEPTION; DRUGS, CHINESE HERBAL; GOSSYPOL; HUMANS; MALE; RESEARCH; TRIPTERYGIUM; UROLOGY;

EID: 0033140222     PISSN: 1008682X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Waites GMH, Kasonde J, editors. Studies in male fertility. Int J Androl 1995; 18 Suppl 1: 1-74.
2. World Health Organization. Laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 3rd ed. Cambridge: Cambridge University Press, 1992. (4th ed to be published in 1999).
3. World Health Organization. Manual for the standardized investigation, diagnosis and management of the infertile couple. Cambridge: Cambridge University Press, 1993. (2nd ed in preparation).
4. Tang GH, Zhong YH, Ma YM, Luo L, Cui K, Luo J, et al. Vasectomy and health: cardiovascular and other diseases following vasectomy in Sichuan Province, People's Republic of China. Int J Epidemiol 1988; 17: 608-17.
5. Pettiti DB. Epidemiological studies in vasectomy. In: Zatuchni GI, Goldsmith A, Spieler JM, Sciarra JJ, editors. Male contraception: advances and future prospects. Philadelphia; Harper & Row; 1986. p 24-33.
6. Farley TMM, Meirik O, Mehta S, Waites GMH. The safety of vasectomy: recent concerns. WHO Bulletin 1993; 71: 413-9.
7. Gu FL, Xia TL, Kong XT. Preliminary study of the frequency of benign prostatic hyperplasia and prostate cancer in China. Urology 1994; 44: 688-911.
8. Li SQ, Goldstein M, Zhu J, Huber D. The no-scalpel vasectomy. J Urol 1991; 145: 341-4.
9. Zhao SC. Vas deferens occlusion by percutaneous injection of polyurethane elastomer plugs: clinical experience and reversibility. Contraception 1990; 41: 453-9.
10. Zhang GY, Wang XH, Chen ZW, Cui YG. Research on male contraception in China. In: Waites GMH, Frick J, Baker HWG, editors. Current advances in andrology. Bologna: Monduzzi Editore; 1997. p 233-9.
11. Soebadi DM, Gardjito W, Mensink HJA. Intravasal injection of formed-in-place medical grade silicone rubber for vas occlusion. Int J Androl 1995; 18 Suppl 1: 45-52.
12. Qian SZ, Hu JH, Ho LX, Sun MX, Huang YZ, Fang JH. The first clinical trial of gossypol on male. In: Turner P. editor. Clinical pharmacology and therapeutics. Proceedings of the First World Congress on Clinical Pharmacology & Therapeutics. London: Macmillan; 1980. p 489-92.
13. Liu ZQ, Liu GZ, Hei LS, Zhang RA, Yu CZ. Clinical trial of gossypol as an antifertility agent. In: Chang CF, Griffin PD, Woolman A, editors. Recent Advances in Fertility Regulation. Geneva: Atar SA; 1981. p 160-3.
14. Prasad MRN, Diczfalusy E. Gossypol. Int J Androl 1982; 5 Suppl: 53-70.
15. Qian SZ, Jing GW, Wu XY, Xu Y, Li YQ, Zhou ZH. Gossypol related hypokalaemia, clinicopharmacologic studies. Chin Med J 1980; 93: 477-82.
16. Frick J, Danner C, Kohle R, Kumit G. Male fertility regulation. In: Cortes-Prieto J, Compos-da-Paz A, Nevese-Castro M, editors. Research on Fertility and Sterility. Lancaster: MTP Press; 1981. p 300-2.
17. Coutinho EM. Clinical studies with gossypol. Arch Androl 1982; 3: 37-8.
18. Morris ID. Gossypol: male contraceptive with potential? IRCS Med Sci 1986; 14: 1177-80.
19. Waller DP, Niu XY, Kim I. Toxicology and mechanism of action of gossypol. In: Zatuchni GI, Goldsmith A, Spieler JM, Sciarra JJ, editors. Male Contraception: Advances and Future Prospects. Philadelphia: Harper & Row; 1986. p 183 -200.
20. Waites GMH. Introduction. Contraception 1988; 37 (2): iv.
21. Waites GMH, Wang C, Griffin PD. Gossypol: reasons for its failure to be accepted as a safe, reversible male antifertility drug. Int J Androl 1998; 21: 8-12.
22. Heywood R. The toxicology of gossypol acetic acid and (-) gossypol. Contraception 1988; 37: 185-90.
23. Liu GZ, Lyle KC, Cao J, Zhu C, Li B. Effects of K salt or a potassium blocker on gossypol-related hypokalaemia. Contraception 1988; 37: 111-7.
24. Michael AE. 11β HSD (11β-hydroxysteroid dehydrogenase) and the mechanism of gossypol-induced hypokalaemia. Int J Androl 1998; 21: 313.
25. Qian SZ. Tripterygium wilfordii: a Chinese herb effective in male fertility regulation. Contraception 1987; 36: 247-63.
26. Lue Y, Sinha Hikim AP, Wang C, Leung A, Baravarian S, Reutrakul V, et al. Triptolide: a potential male contraceptive. J Androl 1998; 19: 479-86.
27. Waites GMH. Male fertility regulation: the challenges for the year 2000. Brit Med Bull 1993; 49: 210-21.
28. Cummings DE, Bremner WJ. Prospects for new hormonal male contraceptives. Endocrinol Metab Clin North Am 1994; 22: 893-922.
29. WHO Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 1990; 336: 955-9.
30. WHO Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril 1996; 65: 821-9.
31. Behre HM, Baus S, Kliesch S, Keck C, Simoni M, Nieschlag E. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders. J Clin Endocrinol Metab 1995; 80: 2394-403.
32. Behre HM, Nieschlag E. New androgen esters alone and in combination with GnRH analogs for male contraception. In: Waites GMH, Frick J, Baker HWG, editors. Current advances in andrology. Bologna: Monduzzi Editore; 1997. p 227-32.
33. WHO Task Force on Methods for the Regulation of Male Fertility. Comparison of two androgens plus depotmedroxyprogesterone acetate for suppression to azoospermia in Indonesian men. Fertil Steril 1993; 60: 1062-8.
34. Wu FCW. Androgen/progestin combinations in male contraception: efficacy and safety. In: Waites GMH, Frick J, Baker HWG, editors. Current advances in andrology. Bologna: Monduzzi Editore; 1997. p 221-6.